Recipharm's latest innovation in the pharmaceutical industry, ReciPredict, is poised to revolutionize the drug development landscape. This cutting-edge platform is designed with Quality by Design (QbD) principles at its core, aiming to streamline tech transfers and manufacturing processes. By
In a significant strategic decision reflective of shifting priorities within the pharmaceutical industry, GSK has announced that it will close its 75-year-old antibiotics manufacturing facility in Ulverston, UK, by 2024. This move comes in the wake of the expiration of the company’s contract to
Advancements in deep technology are revolutionizing the pharmaceutical industry, bringing transformative changes across drug discovery, manufacturing, clinical trials, and distribution. By leveraging technologies such as artificial intelligence (AI), blockchain, and quantum computing, the
Renaissance Lakewood LLC, a prominent pharmaceutical contract development and manufacturing organization (CDMO), recently completed a significant campus enhancement project, fortifying its facilities and operational capabilities in Lakewood, NJ. This massive project marks a milestone for the
PCI Pharma Services, a global Contract Development and Manufacturing Organization (CDMO), has set a precedent by becoming the first to complete the International Coalition of Medicines Regulatory Authorities (ICMRA) inspection at its Bedford, New Hampshire campus. This milestone was achieved under
Aurobindo Pharma, a prominent pharmaceutical manufacturer based in Hyderabad, India, is making significant strides to expand its global footprint. The company is on the verge of commencing production at its new facility in China, while also substantially increasing the output capacity of its Pen-G
